Skip to main content
ConductScienceScienceDex

ScienceDex / Researcher record

Pai, Sara Isabel

From the FY2019 NIH awards this investigator leads as contact PI. The department is the award's.

FY2019 NIH rank #2,834
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder

NIH Funding · FY2019

Linked Award Amount
$2.1M
Full award amounts, FY2019
Award Records
2
Records listing this PI
Award-Linked Rank
#2,834
By linked amount among FY2019 PIs
Earliest Year Loaded
2013
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2013$211,4101#30,741
2014$176,1751#32,699
2015$431,3001#17,666
2016$431,3001#18,319
2017$435,0001#18,629
2019$2,146,5822#2,834
2021$2,046,8382#3,310
2022$1,702,5381#4,654
2023$2,116,9543#3,442

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20131 record
  2. FY20141 record
  3. FY20151 record
  4. FY20161 record
  5. FY20171 record
  6. FY2019 · selected2 records
  7. FY20212 records
  8. FY20221 record
  9. FY20233 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Pai, Sara Isabel. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2019 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2013 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2019 award records by amount

NIH award records listing Pai, Sara Isabel as a PI. Multi-PI records show the full award amount for context.

  • 1P01CA240239-01P01Contact PI
    Strategies to Overcome Immune Resistance in Head and Neck Cancers
    Massachusetts General Hospital
    $1.8M
    award amount
  • 1R01FD006341-01R01Contact PI
    Phase II Trial of Anti-PD1 Therapy for HPV-associated Recurrent Respiratory Papillomatosis (IND#128874)
    Massachusetts General Hospital
    $360.3K
    award amount

Award organization

Organizations that administered FY2019 awards listing Pai, Sara Isabel as a PI.

FY2019 award administered by Massachusetts General Hospital (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2013
    First NIH Award
    Massachusetts General Hospital
  2. 2015
    $500K Cumulative Funding
  3. 2016
    $1M Cumulative Funding
  4. 2016
    R01 Grant Holder
  5. 2017
    Program/Center Grant Leader
  6. 2019
    $2M Cumulative Funding
  7. 2019
    Entered Top 50% Nationally
    Ranked #2834
  8. 2019
    Entered Top 25% Nationally
    Ranked #2834
  9. 2021
    $5M Cumulative Funding

Explore further

Find collaborators for Pai, Sara Isabel

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →